company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36565000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36565000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36565000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1207000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3263000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4470000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32095000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32111000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32111000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32111000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1331000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,28152000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2628000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1088251.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.41
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2536900.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.17
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1100000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q2,2012-01-01,2012-03-31,2013-05-14 21:59:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.41
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2542000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2542000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2542000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1145000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4925000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6070000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3528000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-21000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3501000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3501000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3501000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1330000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4831000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1120400.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.31
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1120400.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.31
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1100000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2012.0,Q3,2012-04-01,2012-06-30,2013-08-12 16:47:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.31
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27859000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27859000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27859000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1152000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4798000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5950000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21909000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,48000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21957000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21957000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21957000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1282000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,18807000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1868000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1158053.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.61
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2637008.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.45
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1200000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q1,2012-10-01,2012-12-31,2014-02-13 16:34:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.61
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1196000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1196000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1196000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1493000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3704000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5197000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4001000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,47000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,214000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,252000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3749000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3749000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3749000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1244000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4993000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2192470.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2192470.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2200000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q2,2013-01-01,2013-03-31,2014-05-12 16:51:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1649000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1649000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1649000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1788000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4039000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5827000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4178000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,40000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4138000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4138000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4138000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4138000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17819813.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17819813.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18000000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q3,2013-04-01,2013-06-30,2014-08-11 18:13:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-4704000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,6053000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1349000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1349000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1750000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4300000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6050000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4701000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,102000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,164000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,258000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4443000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4443000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4443000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5137000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,694000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9788039.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9788039.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9800000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2013.0,Q4,2013-07-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,893000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,893000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,893000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2087000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4263000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6350000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5457000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,109000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,87000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5370000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5370000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5370000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5370000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17949472.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17949472.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17900000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q1,2013-10-01,2013-12-31,2015-02-06 16:11:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2160000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2160000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2160000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2565000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4722000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7287000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5127000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,114000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-186000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-76000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5203000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5203000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5203000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5203000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18353628.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18353628.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18600000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q2,2014-01-01,2014-03-31,2015-05-08 16:16:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42051000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42051000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42051000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2603000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4553000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7156000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,34895000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,106000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-65000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,36000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,34931000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-15122000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50053000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,50053000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,50053000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18528833.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.7
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19203270.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.61
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18500000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 16:09:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.7
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-5104000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,7741000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2637000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2637000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2761000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5202000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7963000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5326000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,138000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,102000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,236000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5090000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-48000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5042000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5042000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5042000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18355000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19185000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18300000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2014.0,Q4,2014-07-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,76392000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1106000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,77498000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77498000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2769000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4519000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7288000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,70210000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,127000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,176000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,301000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70511000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28502000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42009000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42009000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42009000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18603067.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.26
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19283223.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.18
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18600000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:38:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.26
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56961000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,406000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57367000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57367000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3438000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5368000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8806000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,48561000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,229000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,210000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48771000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20018000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28753000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,28753000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28753000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18679898.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.54
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19268565.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.49
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18700000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:07:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.54
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11390000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,209000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11599000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11599000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3643000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6253000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9896000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1703000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,304000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,287000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1990000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-428000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2418000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2418000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2418000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18697104.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19277966.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18600000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:07:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16137000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-1721000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14416000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14416000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3693000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7049000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10742000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3674000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,308000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,203000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,509000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4183000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1629000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5812000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5812000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5812000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18673000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19295000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18700000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2015.0,Q4,2015-07-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47869000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,576000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48445000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48445000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3818000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9033000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12851000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35594000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,356000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,329000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35923000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9734000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26189000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26189000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26189000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18776000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.39
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19269000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.36
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18800000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 16:06:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.39
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13004000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13004000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13004000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4426000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9143000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13569000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-565000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,408000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,472000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-93000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1552000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1645000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1645000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1645000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18921000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18921000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18300000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 16:02:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13978000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13978000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13978000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4282000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10785000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15067000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1089000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,474000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,447000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-642000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,434000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1076000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1076000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1076000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18983000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18983000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17900000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q3,2016-04-01,2016-06-30,2017-08-09 16:07:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13417000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-576000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12841000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12841000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4440000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11500000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15940000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3099000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-34000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,452000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,471000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2628000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-826000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1802000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1802000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1802000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18929000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19224000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19000000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2016.0,Q4,2016-07-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10417000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10417000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10417000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4937000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12526000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17463000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7046000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,549000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,524000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6522000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1542000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4980000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4980000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4980000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19038000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19038000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19200000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:07:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8959000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8959000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8959000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5461000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13004000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18465000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9506000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,564000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,549000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8957000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3565000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5392000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5392000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5392000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19047000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19047000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19300000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 16:06:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7511000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7511000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7511000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5233000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15407000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20640000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13129000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,617000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,600000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12529000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4103000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8426000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8426000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8426000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19081000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19081000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19200000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 16:16:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,75927000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,75927000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,75927000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5118000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16514000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21632000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54295000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-12000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,762000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-114000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,660000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54955000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18447000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36508000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36508000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,36508000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19066000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.91
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19407000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.89
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19000000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2017.0,Q4,2017-07-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.91
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38109000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38109000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38109000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5770000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17962000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23732000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14377000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,919000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,41000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,960000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15337000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3644000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11693000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11693000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11693000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19130000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19918000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19200000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q1,2017-10-01,2017-12-31,2019-02-08 16:06:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44049000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44049000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44049000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5706000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21484000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27190000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16859000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1066000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1066000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17925000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5370000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12555000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12555000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12555000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19206000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20601000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19300000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q2,2018-01-01,2018-03-31,2019-05-10 16:01:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57262000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57262000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57262000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6135000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28487000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34622000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22640000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1338000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1338000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23978000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3690000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20288000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20288000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20288000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19303000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.05
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21017000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19300000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q3,2018-04-01,2018-06-30,2019-08-09 16:06:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.05
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67205000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67205000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,67205000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5830000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26923000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32753000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,34452000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3933000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2504000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1429000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35881000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8461000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27420000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27420000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27420000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19255000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.43
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20650000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.31
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19200000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2018.0,Q4,2018-07-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.43
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69886000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69886000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69886000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7152000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34878000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42030000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,27856000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1885000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1885000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29741000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3730000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26011000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26011000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26011000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19426000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.34
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20810000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19400000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q1,2018-10-01,2018-12-31,2020-02-10 16:06:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.34
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39631000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39631000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39631000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6780000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34155000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40935000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1304000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2245000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2245000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,941000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3204000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4145000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4145000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4145000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19549000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21084000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19700000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q2,2019-01-01,2019-03-31,2020-05-11 16:08:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44367000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44367000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44367000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6151000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34461000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40612000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3755000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2415000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2415000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6170000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-866000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7036000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7036000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7036000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19673000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21105000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19500000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q3,2019-04-01,2019-06-30,2019-08-09 16:06:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51313000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51313000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51313000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6163000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38719000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44882000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6431000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4689000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2415000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2274000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8705000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-486000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9191000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9191000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9191000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19584000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20968000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19600000.0
Enanta Pharmaceuticals Inc,ENTA,,0001177648,2019.0,Q4,2019-07-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
